Journal
JOURNAL OF ADDICTIVE DISEASES
Volume 24, Issue 3, Pages 49-59Publisher
HAWORTH PRESS INC
DOI: 10.1300/J069v24n03_04
Keywords
methadone; incarceration; opiate dependence; HIV; hepatitis C; hepatitis B; tuberculosis
Categories
Funding
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER
- NIAID NIH HHS [P30-AI-42853] Funding Source: Medline
- NIDA NIH HHS [5T32DA13911-03] Funding Source: Medline
- CSAT SAMHSA HHS [H79-TI-014562] Funding Source: Medline
Ask authors/readers for more resources
Injection drug users (IDUs) are at increased risk for HIV, viral hepatitis, and tuberculosis, and making up more than a quarter of the incarcerated population in the United States. Methadone maintenance treatment of opiate addiction is highly effective at reducing drug use, drug-related criminal activity, and risk of HIV transmission. Recently released inmates are at particularly high risk for overdose and disease transmission. Linkage to methadone treatment immediately upon release from incarceration is a promising opportunity to combat disease transmission, facilitate reentry into the community, and reduce recidivism.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available